Close Menu

resignation

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Pacific Biosciences today announced Michael Hunkapiller is replacing Hugh Martin as the company's president and CEO, effective immediately.

The Chairman, President, and CEO resigned yesterday, but the firm did not provide the reasons for his exit.

Rosetta Genomics said that its chief commercialization officer would resign as the company settles into its latest change in corporate direction. But the company is not the only player in the RNAi/microRNA space to experience changes to its management lineup.

A member of Bruker's audit committee resigned earlier this month, leaving the firm short of the minimum number of committee members needed to satisfy a Nasdaq rule.

Pages

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.